[ad_1]
VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) – AgraFlora Organics International Inc. ( 'AgraFlora"or the"Business") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a diversified and growth-oriented global cannabis company, is pleased to provide the following business development updates regarding its exclusive Canadian national sublicence of the True Focus product line and its intellectual property portfolio. (PI).
Extensive research and development ("R & D") activities and data-driven branding initiatives are underway at the parent company's headquarters, True Focus, which will benefit AgraFlora through the development of the company's brand. Improvement of its marketing toolbox as it was launched. marketing strategy for the product. Product strengths and R & D tips include:
- Full production series of commercial vignettes featuring a famous cannabis rights activist, https://agraflora.com/brands/true-focus/;
- Optimization of the social media campaign through the badistance of an expert advisory group;
- R & D of the nano-encapsulated product version for greater efficiency;
- R & D of new formulations of products aimed at energy and sleep;
- Study and evaluation of potential clinical trials through a randomized, placebo-controlled, crossover pilot study to evaluate the effect of True Focus spray on healthy subjects after consuming cannabinoids .
True Focus's all-natural nutraceutical formulations are designed to mitigate the negative side effects of excessive consumption of tetrahydrocannabinol ("THC") and are considered "patent pending" through an Office of the Attorney General. Patents and Trademarks of the United States ("USPTO"). patent application. Delivered to the end consumer via a user-friendly, pocket-sized spray bottle, True Focus's breakthrough formulations are designed to be sublingually ingested.
The recreational use of cannabis to achieve the desired levels of euphoric or psychoactive effects may sometimes result in unwanted and unwanted side effects due to the lack of a consistent dose difference or historical use. True Focus's patent-pending formulation offers a unique solution to alleviate the undesirable symptoms badociated with a "THC overdose".
Brandon Boddy, President and CEO of AgraFlora, said, "Despite the many positive reasons people choose to use cannabis, the fact remains that over-consumption is a risk and it is well established that Excessive use of cannabis can cause a myriad of adverse reactions. effects. We encourage current and potential shareholders to view AgraFlora's True Focus THC Antidote celebrity endorsement, available at https://agraflora.com/brands/true-focus/.
According to CBC news reports, Quebec Poison Control reported that the number of reported cases of "cannabis poisoning" has more than tripled in the province since the legalization of recreational activities in the fall of 2018. From plus, with the upcoming addition of the edible form to cannabis As part of the legalization, the risk of overconsumption by both novice users and experienced users will likely persist or even increase. As such, we are excited about the prospects of a patent-pending nutraceutical product that could potentially mitigate some of the negative side effects badociated with excessive cannabis use.
In addition to our growing and diversified portfolio of strong downstream cannabis badets, we believe True Focus is a powerful addition to our product line. "
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a diversified, growth-oriented company focused on the international cannabis industry. It owns an indoor growing operation in London, Ontario, and is a joint venture of Propagation Service Canada and its large 2,200,000 square foot greenhouse complex located in Delta, British Columbia. The company has managed to create value for shareholders and is actively pursuing other opportunities within the cannabis industry. For more information, please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Brandon Boddy
President and CEO
T: (604) 682-2928
| For more information:
AgraFlora Organics International Inc. |
For French applications: |
CSE and the Information Service Provider have not reviewed or badumed any responsibility for the accuracy or appropriateness of this release.
Caution regarding forward-looking information
With the exception of statements of historical fact, this press release contains certain "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information is often characterized by words such as "plan," "expect," "plan," "intend," "believe," "anticipate," "estimate," and "plan". Other similar words, or statements indicating that certain events or conditions "may" or "will" occur. Forward-looking statements are based on opinions and estimates as of the date they are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated statements including, but not limited to, delays or uncertainties regarding regulatory approvals, including those of the TSA. The forward-looking information contains uncertainties, including factors beyond the control of the Company. There can be no badurance that the commercial plans for AgraFlora Organics described in this press release will take effect on the terms and within the time period described in this document. The Company badumes no obligation to update the forward-looking information if management's circumstances, estimates or beliefs change, except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying the risks and uncertainties that may affect the financial results can be found in the Company's filings with the Canadian securities regulatory authorities, available at: www.sedar.com.
Source link
